Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 1
- 27 July 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (14) , 1559-1562
- https://doi.org/10.1016/s0960-894x(00)00290-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Novel Potent and Selective Central 5-HT3 Receptor Ligands Provided with Different Intrinsic Efficacy. 2. Molecular Basis of the Intrinsic Efficacy of Arylpiperazine Derivatives at the Central 5-HT3 ReceptorsJournal of Medicinal Chemistry, 1999
- Arylpiperazines with Serotonin-3 Antagonist Activity: A Comparative Molecular Field AnalysisJournal of Medicinal Chemistry, 1998
- Novel Potent and Selective Central 5-HT3 Receptor Ligands Provided with Different Intrinsic Efficacy. 1. Mapping the Central 5-HT3 Receptor Binding Site by Arylpiperazine DerivativesJournal of Medicinal Chemistry, 1998
- A New Efficient Synthesis of 6-NitroquipazineHETEROCYCLES, 1998
- Binding of Pinoline on the 5‐Hydroxytryptamine Transporter: Competitive Interaction with [3H] CitalopramBasic & Clinical Pharmacology & Toxicology, 1997
- Synthesis of 123I-and labelled 5-iodo-6-nitroquipazineJournal of Labelled Compounds and Radiopharmaceuticals, 1994
- [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hyfroxytryptamine uptake complex. I. In vitro studiesBrain Research, 1993
- High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: Inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitorsNeuropharmacology, 1991
- Reduction of [3H]6‐nitroquipazine‐labelled 5‐hydroxytryptamine uptake sites in rat brain by 3,4‐methylenedioxymethamphetamineFundamental & Clinical Pharmacology, 1990
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973